Immunohistochemistry was used to detect HE4 expression in 102 cases of endometrial cancer, 30 cases of endometrial atypical hyperplasia, and 20 cases of normal endometrium. The gene discussed is WFDC2; the disease is atypical endometrial hyperplasia.